Article
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Digestive diseases and sciences - 1 Jun 2014
Lee Ju Yup, Kim Nayoung, Kim Min Soo, Choi Yoon Jin, Lee Jung Won, Yoon Hyuk, Shin Cheol Min, Park Young Soo, Lee Dong Ho, Jung Hyun Chae
Abstract excerpt
BACKGROUND: Emerging evidence shows that the eradication rate of proton pump inhibitor (PPI)-based triple therapy for the first-line treatment of Helicobacter pylori (H. pylori) has decreased. AIMS: To clarify the trend of eradication rate of PPI-based triple therapy and to assess the related factors in Korea during the past decade. METHODS: We prospectively prescribed the triple regimen for seven days (PPI +...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
